The Change Tendency of Postoperative Symptoms in Thyroid Cancer Patients
PDF
HTML

How to Cite

Tang, Y. ., Zhang, T., Zhang, Y., Que, Y.-W. ., Lin, D., Qiao, D., Yang, X. T. ., Zhao, J.-F. ., Zhang, Y.-J. ., Wang, G.-R. ., & Wang, Z.-H. . (2021). The Change Tendency of Postoperative Symptoms in Thyroid Cancer Patients. Iranian Red Crescent Medical Journal, 23(12). https://doi.org/10.32592/ircmj.2021.23.12.1153

Abstract

Aims: To detect the health‐related quality of life (HRQoL) of Thyroid cancer (TC) patients and analyze the change tendency of TC patient’s reported symptoms after surgery.

Methods: A total of 102 TC patients who underwent thyroid surgery from September 2020 to January 2021 were enrolled in this study, and received a survey on HRQoL (EORTC QLQ-C30) and disease-specific symptoms (THYCA-QoL) at 1 month and 3 months after surgery.

Results: Almost all the patients experienced TC specific symptoms after surgery. At 1 month after surgery, throat/mouth problems, voice problems, neuromuscular problems, concentration problems, and less interest in sex were the top 5 reported complains. But at 3 months after surgery, less interest in sex was the top 1 reported complain, followed by throat/mouth problems, voice problems, psychological problems, neuromuscular problems and concentration problems. Meanwhile, the scores of most specific symptoms were decreased with the increase of postoperative time, while scores of less interest in sex were increased. Fatigue, insomnia and dyspnea were the most often reported common cancer-related symptoms for TC patients at 1 and 3 months after surgery. Interestingly, the scores of fatigue measured at 3 months after surgery were much lower than those measured at 1 month after surgery.

Conclusions: Throat/mouth problems, voice problems, neuromuscular problems, concentration problems, less interest in sex and fatigue are the important patient reported complains that we should pay more attention after surgery.

https://doi.org/10.32592/ircmj.2021.23.12.1153
PDF
HTML

References

  1. Jo K and Lim DJ. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer. Korean J Intern Med. 2018;33(6):1050-7. doi: 10.3904/kjim.2018.289. [PubMed: 30396251].
  2. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al: 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. doi: 10.1089/thy.2015.0020. [PubMed: 26462967].
  3. Husson O, Haak HR, Buffart LM, Nieuwlaat WA, Oranje WA, Mols F, et al. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol. 2013;52(2):249-58. doi: 10.3109/0284186X.2012.741326. [PubMed: 23181387].
  4. Lan Y, Cao L, Song Q, Jin Z, Xiao J, Yan L, et al. The quality of life in papillary thyroid microcarcinoma patients undergoing lobectomy or total thyroidectomy: A cross-sectional study. Cancer Med. 2021;10(6):1989-2002. doi: 10.1002/cam4.3747. [PubMed: 33638269].
  5. Goldfarb M, Casillas J. Thyroid Cancer-Specific Quality of Life and Health-Related Quality of Life in Young Adult Thyroid Cancer Survivors. Thyroid. 2016;26(7):923-32. doi: 10.1089/thy.2015.0589. [PubMed: 27161396].
  6. Husson O, Haak HR, Mols F, Nieuwenhuijzen GA, Nieuwlaat WA, Reemst PH, et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol. 2013;52(2):447-54.  doi: 10.3109/0284186X.2012.718445. [PubMed: 23013266].
  7. Tan ML, Idris DB, Teo LW, Loh SY, Seow GC, Chia YY, et al. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia Pac J Oncol Nurs. 2014;1(1):22-32. doi: 10.4103/2347-5625.135817. [PubMed: 27981079].
  8. Ficko SL, Pejsa V, Zadnik V. Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires. Radiol Oncol. 2019;53(3):337-47.  doi: 10.2478/raon-2019-0047. [PubMed: 31553711].
  9. Bernardo DC, Li RJ, Jimeno C. Validity and Reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 - Tagalog among Adult Filipinos with Differentiated Thyroid Cancer. J ASEAN Fed Endocr Soc. 2018;33(2):174-180. doi: 10.15605/jafes.033.02.10. [PubMed: 33442124].
  10. Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV, et al. Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol (Oxf). 2011;75(4):544-54. doi: 10.1111/j.1365-2265.2011.04114.x.  . [PubMed: 21615448].
  11. Kumar NB, Fink A, Levis S, Xu P, Tamura R, Krischer J, et al. Thyroid function in the etiology of fatigue in breast cancer. Oncotarget. 2018;9(39):25723-37. doi: 10.18632/oncotarget.25438. [PubMed: 29876020].
  12. Husson O, Nieuwlaat WA, Oranje WA, Haak HR, van de Poll-Franse LV, Mols F, et al. Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid. 2013;23(10):1247-55. doi: 10.1089/thy.2013.0015. [PubMed: 23578315].
  13. Hughes DT, Reyes-Gastelum D, Kovatch KJ, Hamilton AS, Ward KC, Haymart MR, et al. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes. Surgery. 2020;167(1):102-9. doi: 10.1016/j.surg.2019.04.068. [PubMed: 31582311].
  14. To J, Goldberg AS, Jones J, Zhang J, Lowe J, Ezzat S, Gilbert J, Zahedi A, Segal P, Sawka AM, et al. A systematic review of randomized controlled trials for management of persistent post-treatment fatigue in thyroid cancer survivors. Thyroid. 2015;25(2):198-210. doi: 10.1089/thy.2014.0418. [PubMed: 25382050].
  15. Sawka AM, Naeem A, Jones J, Lowe J, Segal P, Goguen J, et al. Persistent posttreatment fatigue in thyroid cancer survivors: a scoping review. Endocrinol Metab Clin North Am. 2014;43(2):475-94. doi: 10.1016/j.ecl.2014.02.007. [PubMed: 24891173].
  16. Rogers SN, Mepani V, Jackson S, Lowe D. Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer. Br J Oral Maxillofac Surg. 2017;55(7):666-73. doi: 10.1016/j.bjoms.2016.09.001. [PubMed: 28648407].
  17. Choi Y, Lee JH, Kim YH, Lee YS, Chang HS, Park CS, et al. Impact of postthyroidectomy scar on the quality of life of thyroid cancer patients. Ann Dermatol. 2014;26(6):693-9. doi: 10.5021/ad.2014.26.6.693. [PubMed: 25473220].